oNH evaluation

Reading File
Asking for Preferences
Finding Sources
Searching the Web

optic nerve head ONH evaluation clinical assessment ophthalmology

Reading File
Finding Sources
Searching Images

optic nerve head evaluation cup disc ratio neuroretinal rim

Reading File
Searching PubMed

optic nerve head evaluation glaucoma

Reading File
Here is a comprehensive overview of Optic Nerve Head (ONH) Evaluation, drawn from Kanski's Clinical Ophthalmology (10th ed.).

Optic Nerve Head (ONH) Evaluation

1. Normal ONH Anatomy

The key structures assessed during ONH evaluation are:
StructureDescription
Neuroretinal Rim (NRR)Orange-pink tissue between the cup edge and disc margin
Optic CupCentral pale depression within the disc
Optic DiscThe visible head of the optic nerve
Peripapillary RetinaSurrounding tissue that may show atrophic changes

2. The ISNT Rule

The normal NRR follows a predictable width hierarchy:
Inferior > Superior > Nasal > Temporal
  • Sensitivity for glaucoma: 81%, but low specificity (32%)
  • Eyes without glaucoma often do not respect this rule
  • A 2026 meta-analysis (PMID: 41212675) is the most recent evidence on ISNT rule diagnostic accuracy

3. Cup/Disc (C/D) Ratio

  • Vertical C/D ratio is preferred over horizontal
  • Only 2% of the population has a C/D ratio >0.7
  • Asymmetry ≥0.2 between eyes raises suspicion for glaucoma — but always exclude a genuine difference in disc size first
  • Small discs → small cups (may be normal); Large discs → large cups (may also be normal)
💡 Tip: Any cupping in a small disc may be pathological; a large disc with a large cup may be entirely healthy.

4. Optic Disc Size

  • Measured by vertical diameter; normal median: 1.5–1.7 mm (white population)
  • Large discs may be more susceptible to IOP-induced lamina cribrosa displacement (relevant in normal tension glaucoma, NTG)
  • Disc size varies by racial group — largest in those of African descent
  • Measured clinically using a slit beam + correction factor (Table 11.3 in Kanski)

5. Glaucomatous Changes at the ONH

Structural signs of glaucomatous damage:

SignDescription
NRR notchingFocal loss, most often inferior or superior
Cup enlargementConcentric or polar
Disc haemorrhageRisk factor for development and progression; requires magnification to detect
Baring of circumlinear vesselsSpace between NRR and superficial vessel → early NRR thinning
BayonetingDouble angulation of vessels due to NRR loss
Laminar dot signExposed lamina cribrosa fenestrations in advancing glaucoma
Sharpened rim/edgeSharper disc margin angle as NRR recedes
Loss of nasal NRRSign of moderately advanced damage
Collateral vesselsUncommon; caused by chronic low-grade circulatory obstruction

Classic glaucomatous subtypes (Fig. 11.9):

  • Focal ischaemic — inferior notch
  • Myopic — temporal crescent + inferior NRR loss
  • Sclerotic — superior shelving, inferior notching
  • Concentrically enlarged — deep, uniform cup enlargement

6. Peripapillary Atrophy (PPA)

Two zones surround the disc:
  • Alpha zone (outer): Superficial RPE changes; larger/more common in glaucomatous eyes
  • Beta zone (inner): Chorioretinal atrophy; larger, more common in glaucoma; risk factor for progression; its location predicts the orientation of visual field loss

7. Retinal Nerve Fibre Layer (RNFL)

  • Arcuate fibres (superotemporal and inferotemporal) are most vulnerable to glaucomatous damage
  • Papillomacular bundle fibres are most resistant
  • RNFL defects (wedge-shaped or diffuse) precede detectable disc and visual field changes
  • Assessed using:
    • Red-free (green) light on slit lamp / fundus photography
    • OCT (optical coherence tomography)
    • Scanning laser polarimetry
⚠️ RNFL defects are not specific to glaucoma — they can occur in neurological disease and in apparently normal individuals.

Key Images

Normal optic disc annotated with cup and disc
Normal optic nerve head: orange NRR, central physiological cup, low vertical C/D ratio
Cup-to-disc ratio measurement annotated
Annotated fundus showing VDD (vertical disc diameter) and VCD (vertical cup diameter) for C/D ratio calculation
ISNT rule diagram
ISNT rule diagram showing inferior (I), superior (S), nasal (N), temporal (T) rim widths with VCD/VDD markers

Recent Evidence Update

  • PMID 41212675 (Eur J Ophthalmol, 2026): Systematic review/meta-analysis on ISNT rule — most current evidence on its diagnostic accuracy for glaucoma
  • PMID 39392516 (Int Ophthalmol, 2024): Comprehensive review of ONH/RNFL imaging modalities in high myopia with glaucoma
Source: Kanski's Clinical Ophthalmology: A Systematic Approach, 10th ed., Chapter 11

Trabecu

Asking for Preferences
Finding Sources
Searching the Web

trabeculectomy surgical procedure steps indications complications ophthalmology

Reading File
Reading File
Searching PubMed

trabeculectomy outcomes complications glaucoma

Reading File
Searching Images

trabeculectomy surgical technique scleral flap bleb glaucoma

Reading File
Reading File
Here is a comprehensive overview of Trabeculectomy, based on Kanski's Clinical Ophthalmology (10th ed.).

Trabeculectomy

Trabeculectomy is glaucoma filtration surgery that lowers IOP by creating a fistula — protected by a superficial scleral flap — to allow aqueous outflow from the anterior chamber to the sub-Tenon space, forming a filtering bleb.
Trabeculectomy mechanism and post-op bleb
Left: cross-section showing scleral flap, ostium, and aqueous flow pathway. Right: post-operative filtering bleb visible at superior limbus.

Indications

  1. Failure of conservative (medical) therapy to achieve adequate IOP control
  2. Progressive deterioration despite seemingly adequate IOP control (including poor adherence)
  3. Primary therapy in advanced disease requiring very low target pressure — early surgery may give superior long-term outcomes, particularly in younger patients
  4. Patient preference — desire to be free of chronic medication

Surgical Technique (Classical Procedure)

StepDetail
PreoperativePupil constricted with pilocarpine 2%
Bridle sutureInserted at superior cornea or superior rectus
Conjunctival flapLimbal or fornix-based flap fashioned superiorly (12 o'clock incision to reduce bleb dysaesthesia)
Episcleral prepEpiscleral tissue cleared, major vessels cauterized
Scleral trapdoorLamellar scleral flap (50% depth) created — rectangular 3×3–4 mm, trapezoidal, or triangular
Flap dissectionDissected anteriorly into clear cornea
ParacentesisMade in temporal peripheral clear cornea
AC entryAlong most of the trapdoor base width
SclerectomyBlock of deep sclera excised, usually with a Kelly punch
Peripheral iridectomyCreated to prevent blockage of the internal sclerostomy (may be omitted in pseudophakic eyes, with caution)
Flap suturingPosterior corners sutured — releasable or lysable sutures to control postoperative leakage
AC reformationBSS injected through paracentesis to test fistula patency
Conjunctival closureSutured; irrigation repeated to produce a bleb, checked for leakage
Postoperative dropsAtropine 1%; steroids + antibiotics 4×/day for 2 weeks, then steroids alone for 8–12 weeks
Intraoperative trabeculectomy with Kelly punch and post-op bleb
Panel (a) Kelly punch creating the sclerostomy; (b) collagen implant under scleral flap; (c) post-op diffuse flat bleb after phacotrabeculectomy with MMC.

Ex-Press Mini-Shunt

A small stainless steel device inserted beneath the scleral flap as an alternative to a Kelly punch. It standardizes the size of the sclerostomy and may reduce early postoperative hypotony.

Antimetabolites in Filtration Surgery

Used to reduce subconjunctival fibrosis and improve long-term IOP control. Used with caution — only with risk factors for failure or in uncomplicated glaucoma at low doses.

Risk Factors for Surgical Failure:

  • Previous failed trabeculectomy or MIGS
  • Previous conjunctival or cataract surgery
  • Secondary glaucoma (inflammatory, neovascular, post-traumatic)
  • Black race, age <65 years
  • Topical medication >3 years (especially sympathomimetics)

5-Fluorouracil (5-FU)

  • Inhibits fibroblast proliferation by retarding DNA synthesis
  • Intraoperative: sponge soaked in 50 mg/ml applied under Tenon flap for 5 minutes
  • Postoperative: subconjunctival injection of 25–50 mg/ml solution
  • Complications: persistent corneal epithelial defects, bleb leakage

Mitomycin C (MMC)

  • Alkylating agent — more potent than 5-FU
  • Typical: 0.2 mg/ml for 2 minutes intraoperatively; up to 0.4 mg/ml for high-risk patients
  • Sponges placed away from the limbus to improve bleb profile
  • Risk: cystic thin-walled bleb → chronic hypotony, late bleb leak, endophthalmitis

Bevacizumab (anti-VEGF)

  • More effective than placebo, but increases risk of bleb encapsulation
  • Not superior to MMC alone; combining with MMC shows no benefit

Complications

1. Shallow Anterior Chamber

Causes: pupillary block, overfiltration, or malignant glaucoma
CauseManagement
Pupillary blockMydriatics; Nd:YAG laser iridectomy
OverfiltrationConservative; pressure dressing; AC reformation; suture tightening
Malignant glaucomaMydriatics + IV mannitol → Nd:YAG anterior hyaloid disruption → pars plana vitrectomy

2. Failure of Filtration

Diagnosis — bleb appearances indicating failure:
  • Flat, avascular bleb
  • Vascularized bleb — episcleral fibrosis
  • Encapsulated bleb (Tenon cyst) — localized, dome-shaped, fluid-filled, engorged vessels
Causes by site:
  • Extrascleral: Subconjunctival/episcleral fibrosis; bleb encapsulation
  • Scleral: Over-tight flap suturing; scleral bed scarring
  • Intraocular: Sclerostomy blockage (vitreous, blood, uveal tissue, membranes)
A healthy functioning bleb is slightly elevated, relatively avascular, and shows superficial microcysts.

3. Bleb-Associated Infection

ConditionDescription
BlebitisInfection without vitreous involvement
EndophthalmitisInfection with vitreous involvement
Blebitis symptoms: painful, red, photophobic, sticky eye Signs: white bleb with inflammatory material, possible anterior uveitis/hypopyon; normal red reflex
Treatment (urgent):
  • Conjunctival swab (do NOT aspirate from within bleb)
  • Topical broad-spectrum antibiotics hourly (e.g. ofloxacin + cephalosporin)
  • Oral co-amoxiclav 500/125 mg TDS + ciprofloxacin 750 mg BD for ≥5 days (or azithromycin 500 mg/day)
  • Steroids only after definite antibiotic response

4. Late Bleb Leakage

  • Positive Seidel test confirms aqueous leak through bleb
  • Risks: thin-walled or MMC blebs
  • Management: pressure dressing, bandage contact lens, surgical revision, or bleb needling with 5-FU

5. Bleb Dysaesthesia

  • Discomfort from a large or anteriorly placed bleb contacting the lid
  • Reduced by placing incisions at 12 o'clock

Recent Evidence

  • PMID 39394492 (Graefe's, 2025): Meta-analysis — PreserFlo MicroShunt vs. trabeculectomy: comparable IOP reduction with a different complication profile
  • PMID 39670502 (Dtsch Arztebl Int, 2025): MIGS vs. trabeculectomy — trabeculectomy remains the gold standard for advanced glaucoma
Source: Kanski's Clinical Ophthalmology: A Systematic Approach, 10th ed., Chapter 11
This is a shared conversation. Sign in to Orris to start your own chat.